Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Central California
1215
mi
from
Madera, CA
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Central California
1215
mi
from
Madera, CA
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Children's Memorial Hospital
609
mi
from
Chicago, IL
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Children's Memorial Hospital
609
mi
from
Chicago, IL
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
New York University Langone Medical Center
1288
mi
from
New York, NY
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
New York University Langone Medical Center
1288
mi
from
New York, NY
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
1286
mi
from
New York, NY
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
1286
mi
from
New York, NY
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
979
mi
from
Winston-Salem, NC
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
979
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
St. Jude Children's Research Hospital
468
mi
from
Memphis, TN
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
St. Jude Children's Research Hospital
468
mi
from
Memphis, TN
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
University of Vermont
1356
mi
from
Burlington, VT
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
University of Vermont
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
1410
mi
from
Seattle, WA
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated:  12/31/1969
Chedoke-McMaster Hospitals
mi
from
Hamilton,
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
Status: Enrolling
Updated: 12/31/1969
Chedoke-McMaster Hospitals
mi
from
Hamilton,
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Western Regional, Arizona
853
mi
from
Phoenix, AZ
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Western Regional, Arizona
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Santa Rosa Memorial Hospital
1351
mi
from
Santa Rosa, CA
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Santa Rosa Memorial Hospital
1351
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Christiana Care Health Services
1195
mi
from
Newark, DE
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Christiana Care Health Services
1195
mi
from
Newark, DE
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Helen F. Graham Cancer Center at Christiana Hospital
1195
mi
from
Newark, DE
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Helen F. Graham Cancer Center at Christiana Hospital
1195
mi
from
Newark, DE
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
MBCCOP - Howard University Cancer Center
1127
mi
from
Washington,
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
MBCCOP - Howard University Cancer Center
1127
mi
from
Washington,
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center CCOP
1322
mi
from
Miami Beach, FL
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center CCOP
1322
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
MBCCOP - JHS Hospital of Cook County
608
mi
from
Chicago, IL
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
MBCCOP - JHS Hospital of Cook County
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Central Illinois
499
mi
from
Decatur, IL
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Central Illinois
499
mi
from
Decatur, IL
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Northern Indiana CR Consortium
671
mi
from
South Bend, IN
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Northern Indiana CR Consortium
671
mi
from
South Bend, IN
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Cedar Rapids Oncology Project
440
mi
from
Cedar Rapids, IA
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Cedar Rapids Oncology Project
440
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
MBCCOP - LSU Health Sciences Center
697
mi
from
New Orleans, LA
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
MBCCOP - LSU Health Sciences Center
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Michigan Cancer Research Consortium
801
mi
from
Ann Arbor, MI
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Michigan Cancer Research Consortium
801
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Beaumont
839
mi
from
Royal Oak, MI
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Beaumont
839
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Metro-Minnesota
548
mi
from
Saint Louis Park, MN
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Metro-Minnesota
548
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Heartland Research Consortium
405
mi
from
Saint Louis, MO
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Heartland Research Consortium
405
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Missouri Baptist Cancer Center
405
mi
from
Saint Louis, MO
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Missouri Baptist Cancer Center
405
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - St. Louis-Cape Girardeau
404
mi
from
Saint Louis, MO
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - St. Louis-Cape Girardeau
404
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Cancer Research for the Ozarks
249
mi
from
Springfield, MO
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Cancer Research for the Ozarks
249
mi
from
Springfield, MO
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Alamance Cancer Center at Alamance Regional Medical Center
1018
mi
from
Burlington, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Alamance Cancer Center at Alamance Regional Medical Center
1018
mi
from
Burlington, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Southeastern Medical Oncology Center - Goldsboro
1114
mi
from
Goldsboro, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Southeastern Medical Oncology Center - Goldsboro
1114
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Pardee Memorial Hospital
865
mi
from
Hendersonville, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Pardee Memorial Hospital
865
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
High Point Regional Hospital
988
mi
from
High Point, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
High Point Regional Hospital
988
mi
from
High Point, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Caldwell Memorial Hospital
907
mi
from
Lenoir, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Caldwell Memorial Hospital
907
mi
from
Lenoir, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Southeast Cancer Control Consortium
971
mi
from
Winston-Salem, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Southeast Cancer Control Consortium
971
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Comprehensive Cancer Center
974
mi
from
Winston-Salem, NC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Comprehensive Cancer Center
974
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Columbus
810
mi
from
Columbus, OH
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Columbus
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Cancer Centers of the Carolinas - Eastside
884
mi
from
Greenville, SC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Cancer Centers of the Carolinas - Eastside
884
mi
from
Greenville, SC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
South Carolina Cancer Specialists, PA at Hilton Head Medical Center
mi
from
Hilton Head Island, SC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
South Carolina Cancer Specialists, PA at Hilton Head Medical Center
mi
from
Hilton Head Island, SC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
CCOP - Upstate Carolina
903
mi
from
Spartanburg, SC
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
CCOP - Upstate Carolina
903
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Danville Regional Medical Center
1013
mi
from
Danville, VA
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Danville Regional Medical Center
1013
mi
from
Danville, VA
Click here to add this to my saved trials
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Ravenel Oncology Center at Memorial Hospital of Martinsville and Henry County
989
mi
from
Martinsville, VA
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Ravenel Oncology Center at Memorial Hospital of Martinsville and Henry County
989
mi
from
Martinsville, VA
Click here to add this to my saved trials
CT Scans in Screening for Lung Cancer in Current and Former Smokers
Development of a Lung Cancer-Screening Program at the University of Nebraska Medical Center: A Feasibility Study
Status: Enrolling
Updated:  12/31/1969
UNMC Eppley Cancer Center at the University of Nebraska Medical Center
259
mi
from
Omaha, NE
CT Scans in Screening for Lung Cancer in Current and Former Smokers
Development of a Lung Cancer-Screening Program at the University of Nebraska Medical Center: A Feasibility Study
Status: Enrolling
Updated: 12/31/1969
UNMC Eppley Cancer Center at the University of Nebraska Medical Center
259
mi
from
Omaha, NE
Click here to add this to my saved trials
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
801
mi
from
Atlanta, GA
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
515
mi
from
Austin, TX
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
515
mi
from
Austin, TX
Click here to add this to my saved trials
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
341
mi
from
Bedford, TX
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
341
mi
from
Bedford, TX
Click here to add this to my saved trials
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
340
mi
from
Dallas, TX
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
340
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
348
mi
from
Fort Worth, TX
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
348
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
8648
mi
from
Randwick,
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
8648
mi
from
Randwick,
Click here to add this to my saved trials
Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
A Study of RXDX-106, an Oral Immunomodulatory TYRO3, AXL, and MER (TAM) Tyrosine Kinase Inhibitor, in Patients With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated:  12/31/1969
START
571
mi
from
San Antonio, TX
Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
A Study of RXDX-106, an Oral Immunomodulatory TYRO3, AXL, and MER (TAM) Tyrosine Kinase Inhibitor, in Patients With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 12/31/1969
START
571
mi
from
San Antonio, TX
Click here to add this to my saved trials